325 related articles for article (PubMed ID: 18004570)
1. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
[TBL] [Abstract][Full Text] [Related]
2. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
[TBL] [Abstract][Full Text] [Related]
3. [Study of effect of mifepristone on apoptosis of human ovarian cancer cell line 3AO].
Li Q; Li JJ; Zhao XB; Ji M
Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):625-8. PubMed ID: 14728868
[TBL] [Abstract][Full Text] [Related]
4. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
Zhang H; Lü JJ; Gao QZ; Zhang J
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
[TBL] [Abstract][Full Text] [Related]
5. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells.
Li A; Felix JC; Minoo P; Amezcua CA; Jain JK
Fertil Steril; 2005 Jul; 84(1):202-11. PubMed ID: 16009178
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
[TBL] [Abstract][Full Text] [Related]
7. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
9. High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.
Moe BG; Vereide AB; Orbo A; Sager G
Anticancer Res; 2009 Apr; 29(4):1053-8. PubMed ID: 19414345
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study of membrane estrogen receptor expression in endometrial carcinoma cells].
Wang ZQ; Wang JL; Wei LH; Zhao D; Gao M; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):471-5. PubMed ID: 17083814
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
12. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Moe BT; Vereide AB; Orbo A; Jaeger R; Sager G
Anticancer Res; 2009 Apr; 29(4):1047-52. PubMed ID: 19414344
[TBL] [Abstract][Full Text] [Related]
13. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
[TBL] [Abstract][Full Text] [Related]
14. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells].
Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY
Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028
[TBL] [Abstract][Full Text] [Related]
15. Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells.
Yu Z; Shah DM
Gynecol Oncol; 2007 Sep; 106(3):541-8. PubMed ID: 17590421
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E
Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238
[TBL] [Abstract][Full Text] [Related]
17. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
19. Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.
Rose FV; Barnea ER
Oncogene; 1996 Mar; 12(5):999-1003. PubMed ID: 8649817
[TBL] [Abstract][Full Text] [Related]
20. Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3.
Fauvet R; Dufournet Etienne C; Poncelet C; Bringuier AF; Feldmann G; Daraï E
Oncol Rep; 2006 Apr; 15(4):743-8. PubMed ID: 16525653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]